Related references
Note: Only part of the references are listed.Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis
Lanxiao Cao et al.
JOURNAL OF NEUROLOGY (2022)
Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study
Diego Santos Garcia et al.
NEUROLOGICAL SCIENCES (2022)
Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 study
Masahiro Nomoto et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)
Overnight switch from rasagiline to safinamide in Parkinson's disease patients with motor fluctuations: a tolerability and safety study
F. Stocchi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Safinamide improves executive functions in fluctuating Parkinson's disease patients: an exploratory study
Domiziana Rinaldi et al.
JOURNAL OF NEURAL TRANSMISSION (2021)
SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease
Ana Gomez-Lopez et al.
BRAIN SCIENCES (2021)
Effects of safinamide adjunct therapy on pain in patients with Parkinson's disease: Post hoc analysis of a Japanese phase 2/3 study
Yoshio Tsuboi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)
Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study
Diego Santos Garcia et al.
BRAIN SCIENCES (2021)
Selegiline reduces daytime sleepiness in patients with Parkinson's disease
Marco Gallazzi et al.
BRAIN AND BEHAVIOR (2021)
Switch from rasagiline to safinamide in fluctuating Parkinson's disease patients: a retrospective, pilot study
Edoardo Bianchini et al.
NEUROLOGICAL RESEARCH (2021)
Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study
Nobutaka Hattori et al.
PARKINSONISM & RELATED DISORDERS (2020)
Long-term safety and efficacy of safinamide as add-on therapy in levodopa-treated Japanese patients with Parkinson's disease with wearing-off: Results of an open-label study
Yoshio Tsuboi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Safinamide Differentially Modulates In Vivo Glutamate and GABA Release in the Rat Hippocampus and Basal Ganglia
Michele Morari et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach
Angelo Antonini et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Rasagiline improves polysomnographic sleep parameters in patients with Parkinson's disease: a double-blind, baseline-controlled trial
W. Schrempf et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study
Claudio Liguori et al.
PARKINSONISM & RELATED DISORDERS (2018)
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations A Randomized Clinical Trial
Anthony H. V. Schapira et al.
JAMA NEUROLOGY (2017)
Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease - Clinical practice recommendations
Claudia Trenkwalder et al.
PARKINSONISM & RELATED DISORDERS (2015)
Two-Year, Randomized, Controlled Study of Safinamide as Add-on to Levodopa in Mid to Late Parkinson's Disease
Rupam Borgohain et al.
MOVEMENT DISORDERS (2014)
The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial
A. Marquet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Management of punding in Parkinson's disease: an open-label prospective study
A. Fasano et al.
JOURNAL OF NEUROLOGY (2011)
Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers
Andrea Francesco Daniele Di Stefano et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Pathological Gambling in Parkinson Disease Is Reduced by Amantadine
Astrid Thomas et al.
ANNALS OF NEUROLOGY (2010)
Parkinson's Disease Symptoms: The Patient's Perspective
Marios Politis et al.
MOVEMENT DISORDERS (2010)